Collaborative effort to improve care for patients with cardiogenic shock
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
This study is trying to gather information on how to better care for patients with cardiogenic shock caused by heart problems to help improve their treatment and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Locations | 3 sites (Weston, Florida and 2 other locations) |
| Trial ID | NCT05185492 on ClinicalTrials.gov |
What this trial studies
This international prospective registry aims to enhance understanding of the management and outcomes of patients experiencing cardiogenic shock across four high-volume care centers. By collecting comprehensive data on clinical courses and outcomes, the study seeks to identify factors associated with adverse outcomes and inform future clinical practices. The registry will focus on patients with cardiogenic shock stemming from acute myocardial infarction and acute decompensated heart failure, utilizing a standardized approach to care. The findings may serve as a blueprint for future clinical trials and improve treatment protocols.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with cardiogenic shock due to acute myocardial infarction or acute decompensated heart failure.
Not a fit: Patients whose shock is not primarily cardiac in origin, such as those with septic or hemorrhagic shock, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies and better outcomes for patients suffering from cardiogenic shock.
How similar studies have performed: While there have been various studies on cardiogenic shock, this collaborative approach is novel and aims to fill gaps left by previous research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary diagnosis of cardiogenic shock at time of index evaluation; including acute myocardial infarction- and acute decompensated heart failure-cardiogenic shock phenotypes * Patients with cardiac arrest complicating cardiogenic shock and those with massive pulmonary embolism with right ventricular cardiogenic shock will also be eligible for the registry Exclusion Criteria: * Patients with shock not due to primary cardiac etiology will be excluded. These include septic, hemorrhagic, and anaphylactic shock.
Where this trial is running
Weston, Florida and 2 other locations
- Cleveland Clinic Florida — Weston, Florida, United States (Recruiting)
- Inova Heart and Vascular Institute — Falls Church, Virginia, United States (Recruiting)
- University of Toronto — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Stavros Drakos, M.D. — University of Utah
- Study coordinator: John Kirk
- Email: john.kirk@hsc.utah.edu
- Phone: 801-585-2944
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.